Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactomedin-like protein 2B is a secreted glycoprotein encoded by the OLFML2B gene on human chromosome 1q23.3[1][2]. It is a member of the olfactomedin domain-containing protein family, which includes more than a dozen extracellular proteins often involved in neural and ocular development, as well as extracellular matrix (ECM) interactions[1][5]. OLFML2B is closely related to OLFML2A, and both are sometimes referred to as photomedins due to their expression in retinal tissue[1]. OLFML2B demonstrates broad tissue expression, especially in the retina (ganglion cell and inner nuclear layers, inner segment of the photoreceptor layer, and retinal pigmented epithelium)[1]. Functionally, the protein is known to bind preferentially to extracellular matrix components such as chondroitin sulfate-E and heparin[1][5]. The precise biological function of OLFML2B remains to be elucidated, but, like other olfactomedin domain-containing proteins, it may participate in cell-matrix adhesion, neural differentiation, or tissue patterning[1][5]. There is currently no evidence supporting its use as a therapeutic target or as a clinically actionable biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactomedin-like protein 2B (OLFML2B).